Products

Signal Tracker Data Platform Data Enrichment API Intelligence desk

Solutions

Inward Investment & Aftercare Deal Origination Executive Search Corporate Development Signal-Based Outbound Competitive Intelligence Funding Signals Competitor Monitoring For Sales Teams For Founders For Agencies For Investors

Explore

Companies Live Signals Markets Trends

Resources

Signal Checker Blog Integrations FAQ Contact Pricing
Login Book a demo
MODAG logo — Neuroscience Solutions

MODAG

Neuroscience Solutions

Founded 2013 Germany Germany 12 employees Series A Biotechnology, Health and Wellness

General Information

Company Name MODAG
Founded Year 2013
Location Germany Germany +1
Employees 12
Industries Biotechnology, Health and Wellness
Funding Stage Series A
Social

Get notified when MODAG moves

Funding, new markets, leadership changes, hiring surges — one e-mail, only when something happens.

Free · no account needed

About MODAG

MODAG, founded in 2013, is a trailblazing biotechnology firm headquartered in Germany, prominently known for its focus on Neuroscience Solutions. The company specializes in the research and development of cutting-edge therapeutics and diagnostics for neurodegenerative diseases. It operates from the Hochtechnologiepark Wendelsheim with additional R&D facilities in Munich and Göttingen.

MODAG distinguishes itself through its strategic collaborations with top-tier US and European research institutions, enabling it to translate its pioneering discoveries into clinical applications swiftly. The company's interdisciplinary management team fuels its agile operations and clinical advancements. Among its notable innovations, MODAG is advancing a new oligomer modulator designed to address Multiple System Atrophy (MSA) and other synucleinopathies like Parkinson's disease with potential first-in-class, disease-modifying drugs aimed at halting progression.

Despite no recent investment recorded, MODAG's robust portfolio of patented compounds makes it an attractive prospect for investors looking to support high-impact, growth-oriented biotechnology ventures.

Taxonomy: neurodegenerative diseases, therapeutics development, diagnostics innovation, synucleinopathies, Multiple System Atrophy, Parkinson's disease, disease-modifying therapies, early diagnosis, oligomer modulator, small molecule therapeutics, clinical research, patented active compounds, interdisciplinary R&D, clinical proof-of-concept

Services & Products

Development of therapeutics for neurodegenerative diseases
Innovative diagnostics for early detection
Clinical trials management
Research and development of oligomer modulators

Target Customers

Patients with Parkinson's Disease Patients with Multiple System Atrophy Healthcare professionals in neurology Pharmaceutical companies

No funding data available for MODAG yet.

Get notified when MODAG raises funding

MODAG Alternatives & Competitors

MODAG vs
Allyx Therapeutics
Allyx Therapeutics United States

Protecting Synapses and Reversing Neurodegeneration

Series Unknown
5 employees
Biotechnology, Health Care
MODAG vs
T3D Therapeutics, Inc.
T3D Therapeutics, Inc. United States

Developing a potentially disease-modifying, new drug treatment for Alzheimer’s and other neurodegene...

Series Unknown
12 employees
Biotechnology
MODAG vs
PepGen
PepGen United States

Better Technology. Better Delivery. Developing a new generation of disease-modifying therapies.

IPO
64 employees
Biotechnology

FAQ About MODAG

Neuroscience Solutions
MODAG was founded in 2013.
MODAG is headquartered in Germany.
MODAG operates in the following industries: Biotechnology, Health and Wellness.
MODAG has approximately 12 employees.
MODAG offers: Development of therapeutics for neurodegenerative diseases, Innovative diagnostics for early detection, Clinical trials management, Research and development of oligomer modulators.
Top alternatives and competitors to MODAG include Allyx Therapeutics, T3D Therapeutics, Inc., PepGen, Simcha Therapeutics, NeuroSoV. These companies operate in related industries and serve comparable markets. You can compare them side by side on Bounce Watch.
MODAG and Allyx Therapeutics are both companies in similar industries. Compare their funding, team size, growth signals, and market position on Bounce Watch to see which one fits your needs.

Don't just browse. Track.

Signal Tracker monitors MODAG and millions of companies for funding rounds, hiring surges, product changes, and 40+ signal types — so you never miss an opportunity.

See how it works

One analytics cookie (Google Analytics). Cookie Policy